POTS and Dysautonomia: Why Your Heart Races When You Stand and What It Means

Quick Answer: Postural Orthostatic Tachycardia Syndrome (POTS) is a form of dysautonomia where standing up triggers a heart rate increase of 30 beats per minute or more within 10 minutes, without a significant drop in blood pressure. Affecting an estimated 1 to 3 million Americans — roughly 80% of them women aged 15 to 50 — POTS often develops after a viral illness, pregnancy, surgery, or trauma, and the average patient waits 4 to 5 years before receiving a correct diagnosis.

Key Facts

• POTS is defined by a heart rate increase of at least 30 bpm (40 bpm for adolescents aged 12–19) within 10 minutes of standing, without orthostatic hypotension.
• Approximately 80% to 85% of POTS patients are female, with onset most commonly occurring between ages 15 and 50.
• Research published in the Journal of the American College of Cardiology found that the average diagnostic delay is 4.7 years, with many patients seeing 5 or more physicians before receiving a correct diagnosis.
• A 2019 survey of over 4,800 POTS patients by Dysautonomia International reported that 25% were unable to work or attend school due to symptoms, and 75% experienced functional impairment rated as equivalent to congestive heart failure or COPD on quality-of-life measures.
• Studies suggest that up to 50% of POTS cases begin after a viral infection, making post-viral dysautonomia a leading trigger — a pattern that has drawn renewed attention since the COVID-19 pandemic.

What Is Dysautonomia and How Does POTS Fit In?

Dysautonomia is an umbrella term for conditions in which the autonomic nervous system — the part of the nervous system that controls involuntary functions like heart rate, blood pressure, digestion, and temperature regulation — does not work properly. The autonomic nervous system has two main branches: the sympathetic system (which activates the "fight or flight" response) and the parasympathetic system (which drives "rest and digest"). In a healthy person, standing up triggers a rapid but brief sympathetic response: blood vessels in the legs constrict, heart rate increases slightly, and blood pressure stays stable. Within seconds, the system recalibrates and everything settles.

In someone with POTS, this mechanism breaks down. When the person stands, blood pools in the lower extremities — partly because nerves fail to signal blood vessels to constrict adequately, and partly because some patients have low blood volume to begin with. The heart compensates by racing, sometimes reaching 120, 140, or even 160 beats per minute, in an attempt to push enough blood to the brain. But the vessels never catch up, so the heart keeps pounding. The brain, meanwhile, is not getting the oxygen it needs, which is why lightheadedness, brain fog, and near-fainting episodes are common.

POTS is not a single disease with a single cause. Researchers have identified several subtypes. Neuropathic POTS involves damage to the small nerve fibers that control blood vessel constriction in the legs and abdomen. Hyperadrenergic POTS is characterized by elevated norepinephrine levels — sometimes 600 pg/mL or higher while standing — and patients often experience tremors, anxiety-like sensations, and a spike in blood pressure upon standing rather than the stable pressure seen in other subtypes. Hypovolemic POTS involves low blood volume, sometimes as much as 20% to 30% below normal, which means the heart has less fluid to work with. Many patients exhibit features of more than one subtype, which complicates treatment and explains why a single approach rarely works for everyone.

The prevalence of POTS has been estimated at 0.2% to 1% of the population in developed countries, which translates to roughly 500,000 to 3 million people in the United States alone. Before the COVID-19 pandemic, POTS was considered a niche diagnosis — something most medical students heard about in a single lecture slide, if at all. Since 2020, however, a wave of post-COVID POTS cases has forced the condition into broader clinical awareness. A 2023 review in Nature Reviews Cardiology noted that POTS-like syndromes are now among the most common cardiovascular complications of long COVID, and major medical centers have opened dedicated dysautonomia clinics in response.

Why Is POTS So Frequently Missed by Doctors?

The diagnostic journey for most POTS patients follows a pattern that has become grimly predictable. It begins with symptoms that sound diffuse and nonspecific: fatigue, dizziness, palpitations, brain fog, exercise intolerance. A young woman — and it is most often a young woman — visits her primary care physician. She may be told she is anxious, dehydrated, or simply "out of shape." Blood work comes back normal. An EKG shows sinus tachycardia, which is not itself dangerous, so the doctor reassures her and sends her home.

The symptoms continue. She returns, or sees a different doctor. This time, maybe she gets a Holter monitor — a 24-hour or 48-hour portable EKG. The results show episodes of tachycardia, but the clinician may not have correlated those episodes with postural changes. Without a specific tilt-table test or an active stand test, the relationship between the tachycardia and the simple act of standing can remain invisible. This is the diagnostic gap: the tools most doctors reach for first are not designed to catch POTS.

A 2019 study published in BMJ Open surveyed POTS patients across multiple countries and found that 75% had been told at some point that their symptoms were psychiatric in nature before receiving a POTS diagnosis. The average patient saw 5 to 7 different physicians over a period of years. The combination of a predominantly young, female patient population, normal routine lab results, and a condition that does not show up on standard imaging creates a perfect storm for dismissal. This is not to say that individual doctors are negligent — it is a systemic problem of medical education, where autonomic disorders receive minimal curricular time compared to their prevalence and impact on quality of life.

The tilt-table test remains the gold standard for diagnosing POTS, but it is not available in every clinic. An alternative is the active stand test, sometimes called the "poor man's tilt-table," which can be performed in a primary care office: the patient lies supine for 5 to 10 minutes while heart rate and blood pressure are recorded, then stands and has measurements taken at 2, 5, and 10 minutes. A heart rate increase of 30 bpm or more (40 bpm in adolescents) without a significant drop in blood pressure is diagnostic. This test requires no special equipment beyond a blood pressure cuff and a pulse oximeter, yet it remains underutilized — partly because many clinicians simply do not think to look for POTS.

How POTS Is Treated: A Multi-Layered Approach

Treatment for POTS is rarely a single intervention. It is a combination of lifestyle modifications, pharmacological support, and physical reconditioning — and the specific mix varies from patient to patient depending on their subtype, symptom severity, and comorbidities.

The first-line approach almost always involves increasing fluid and salt intake. The goal is to expand blood volume, which directly addresses the hypovolemic component seen in many POTS patients. Typical recommendations include 2 to 3 liters of water per day and 3 to 10 grams of sodium, often through a combination of dietary salt and electrolyte supplements. These numbers are not arbitrary — they come from evidence showing that plasma volume can be 15% to 25% lower than expected in a significant subset of POTS patients. Compression garments, particularly waist-high compression stockings providing 30 to 40 mmHg of pressure, can reduce venous pooling in the legs and abdomen, helping more blood return to the heart and brain.

When lifestyle measures are not enough, medications come into play. Beta blockers like propranolol or metoprolol can slow the heart rate, though they must be dosed carefully — too much can worsen fatigue. Ivabradine, a medication that reduces heart rate without lowering blood pressure, has shown promise specifically for POTS patients, particularly those with the hyperadrenergic subtype. Midodrine, a vasoconstrictor, helps tighten blood vessels and reduce venous pooling. Fludrocortisone promotes sodium and water retention by the kidneys, expanding blood volume. Each of these addresses a different piece of the puzzle, and finding the right combination often requires trial and error under close medical supervision.

Physical reconditioning is perhaps the most important — and most counterintuitive — part of POTS treatment. Exercise initially makes symptoms worse, which leads many patients to avoid it, which leads to deconditioning, which in turn worsens POTS symptoms. This creates a vicious cycle. The Levine Protocol, developed at the University of Texas, is a structured exercise program designed specifically for POTS patients. It starts with recumbent exercises — rowing, recumbent cycling, swimming — that do not require upright posture, and gradually progresses to upright activities over a period of months. A 2011 study in the Journal of the American College of Cardiology found that after 3 months of the protocol, patients' heart rate responses to standing decreased by an average of 15 to 20 bpm, and 71% of participants no longer met the diagnostic criteria for POTS. However, the protocol is demanding, and not all patients can tolerate it, especially those with severe fatigue or comorbid conditions like ME/CFS.

Conventional vs Integrative Approaches to POTS Management

| Approach | Core Interventions | Typical Cost Range | Evidence Level | Considerations |

|----------|-------------------|---------------------|----------------|----------------|

| Conventional Cardiology | Beta blockers, ivabradine, midodrine, fludrocortisone; tilt-table diagnosis; salt/fluid loading | $500–$3,000 for initial workup (with insurance); medications $10–$200/month | Moderate to strong for individual medications; weaker for combination protocols | Medications manage symptoms but do not address root autonomic dysfunction; side effects include fatigue, bradycardia, and hypotension |

| Structured Exercise (Levine Protocol) | 3-month graduated recumbent-to-upright exercise program; 4–5 sessions per week | $0–$500 for equipment (recumbent bike or rowing machine); free if using gym membership | Strong — one study showed 71% remission of POTS criteria after 3 months | High dropout rate due to exercise intolerance; requires significant patient motivation; may not be suitable for severe ME/CFS overlap |

| Dietary & Nutritional Support | High-sodium diet (3–10g/day), 2–3L water, small frequent meals, gluten/dairy elimination trials, vitamin D, B12, iron optimization | $50–$200/month for supplements and specialty foods | Moderate for salt/fluid; limited but growing for micronutrient optimization | Low risk; dietary changes are patient-controlled; results can take 4–8 weeks |

| Integrative / Functional Medicine | Comprehensive autonomic testing, micronutrient panels, gut health assessment, acupuncture, herbal adaptogens (licorice root, astragalus), vagal nerve stimulation | $1,500–$5,000 initial assessment; $200–$500/month ongoing | Emerging — limited RCTs but growing clinical experience; acupuncture has small trials showing HRV improvement | Addresses multiple systems simultaneously; requires careful coordination among practitioners; platforms like rebirthealth.com can help patients access multi-specialty review |

| Mind-Body & Cognitive Approaches | CBT for symptom management, biofeedback, mindfulness-based stress reduction, graded exposure therapy | $100–$250/session; 8–16 sessions typically recommended | Moderate for quality of life improvement; limited for direct autonomic outcomes | Does not treat POTS directly but can reduce secondary anxiety and improve coping; valuable adjunct rather than standalone treatment |

Step-by-Step: What to Do If You Suspect You Have POTS

1. Start tracking your heart rate at home. Use a pulse oximeter, a smartwatch, or a blood pressure cuff with heart rate capability. Measure your heart rate while lying down for at least 5 minutes, then stand up and record it at 2, 5, and 10 minutes. A sustained increase of 30 bpm or more (40 bpm if you are under 19) without a significant drop in blood pressure is suggestive of POTS. Document these readings over several days and at different times — symptoms can fluctuate throughout the day and may be worse in the morning.

2. Compile a symptom journal that goes beyond heart rate. Note when you feel lightheaded, when brain fog is at its worst, what you ate and drank, how well you slept, and whether any other symptoms — gastrointestinal distress, temperature dysregulation, exercise intolerance, blood pooling in the legs — appear. This type of detailed record accomplishes two things: it helps your doctor see patterns that might not emerge in a single office visit, and it signals that you are approaching your health systematically, which can shift the clinical dynamic.

3. Find a physician who understands autonomic disorders. This is often the hardest step. Cardiologists, neurologists, and electrophysiologists are the specialists most likely to diagnose and treat POTS, but even within these fields, familiarity with dysautonomia varies widely. Organizations like Dysautonomia International maintain physician directories. When you call to make an appointment, ask directly whether the practice evaluates and treats patients with POTS or dysautonomia. If the answer is vague or dismissive, keep looking. Telemedicine has expanded access significantly — you are no longer limited to providers in your immediate geographic area.

4. Request specific testing. A tilt-table test is the definitive diagnostic tool, but an active stand test performed in the office is a reasonable alternative if tilt-table testing is unavailable. Ask for catecholamine testing (norepinephrine levels while supine and standing) to help identify the hyperadrenergic subtype. Basic blood work should include a complete blood count, iron studies, vitamin B12, vitamin D, thyroid panel, and morning cortisol — these can rule out or identify conditions that mimic or exacerbate POTS. Some patients also benefit from a quantitative sudomotor axon reflex test (QSART) to assess small fiber nerve function.

5. Build a multi-modal treatment plan. Work with your physician to layer interventions: start with fluid and salt loading, add compression garments, and introduce medications one at a time so you can assess what each one does. Discuss the possibility of a structured exercise protocol, but be honest about what you can tolerate — pushing through severe symptoms does not help and can trigger setbacks. If you are not improving after 3 to 6 months of a given approach, reassess. Some patients need to explore integrative options that combine conventional cardiology with nutritional support, autonomic retraining, and management of comorbidities like MCAS or Ehlers-Danlos syndrome, which frequently co-occur with POTS. Platforms that offer multi-specialty case review, such as rebirthealth.com, can help patients access coordinated perspectives when individual specialists are working in silos.

FAQ

What is the difference between POTS and general anxiety?

POTS and anxiety can look similar — both involve a racing heart, sweating, and a sense of unease — but the underlying mechanism is entirely different. In POTS, the tachycardia is a direct physiological response to standing: blood pools in the lower body, the heart compensates, and symptoms emerge mechanically. In anxiety, the racing heart is driven by the brain's threat-response system, not by postural change. A key distinguishing feature is that POTS symptoms are positional — they improve or resolve when the person lies down — while anxiety symptoms are typically not tied to posture. Many POTS patients are initially misdiagnosed with anxiety disorders, and the resulting delay in appropriate treatment averages several years, according to a longitudinal study published in the Journal of Internal Medicine.

Can POTS go away on its own?

For some patients, particularly adolescents who develop POTS after a growth spurt or a viral illness, symptoms can improve significantly or resolve over a period of 2 to 5 years. A 2016 study in Pediatrics followed adolescents with POTS and found that approximately 50% to 60% experienced substantial symptom improvement or resolution within 5 years of diagnosis. For adults, the prognosis is more variable — some recover fully, many improve with treatment but continue to manage symptoms long-term, and a subset remain significantly disabled. The factors that predict recovery are not fully understood, but early diagnosis, consistent treatment adherence, and the absence of comorbid conditions like Ehlers-Danlos syndrome appear to be associated with more favorable outcomes.

Is POTS considered a disability?

POTS can be disabling, and in many jurisdictions it qualifies as a disability under relevant laws. The 2019 Dysautonomia International patient survey found that 25% of respondents were unable to work or attend school, and many more reported substantial limitations in daily functioning. The Social Security Administration in the United States does not list POTS as a specific impairment in its Blue Book, but patients can qualify for disability benefits if they can demonstrate that their symptoms limit functional capacity to the point where they cannot maintain gainful employment. Documentation of objective findings — tilt-table results, catecholamine levels, and documented functional limitations — is essential for any disability claim.

What is the connection between COVID-19 and POTS?

Long COVID has brought a surge of new POTS cases. A 2022 study in Heart Rhythm found that among patients referred for post-COVID tachycardia, approximately 25% to 50% met diagnostic criteria for POTS. The mechanism appears to involve several pathways: direct viral damage to autonomic nerves, autoimmune activation producing antibodies that interfere with autonomic receptors, and the deconditioning that follows prolonged illness. The overlap between long COVID and POTS has been so significant that some researchers now refer to "post-COVID POTS" as a distinct clinical entity. The increased awareness has led to faster diagnosis for new patients and more research funding for autonomic disorders overall, which means the diagnostic delays that characterized POTS for decades may be shortening for the post-COVID cohort.

What should I avoid if I have POTS?

Several things can worsen POTS symptoms, and avoiding them is a foundational part of management. Large, carbohydrate-heavy meals divert blood flow to the gut for digestion, which can trigger postprandial hypotension and tachycardia — eating smaller, more frequent meals with a balance of protein, fat, and complex carbohydrates helps. Prolonged standing, especially in hot environments, causes excessive venous pooling; shower chairs and avoiding hot showers are practical recommendations. Alcohol is a vasodilator and a diuretic, both of which can worsen symptoms. Dehydration, even mild, can reduce already-low blood volume further. High-intensity upright exercise without proper progression can trigger crashes; the key is to start recumbent and build up slowly under guidance. Heat exposure more broadly — hot weather, saunas, hot baths — can be especially problematic because heat causes vasodilation, which directly counteracts the vasoconstriction that POTS patients depend on to maintain blood pressure when upright.

---

This article is for informational purposes only and does not constitute medical advice. POTS is a complex condition that requires individualized assessment and treatment by qualified healthcare professionals. Consult with your physician before making changes to your treatment plan. Rebirth Health (rebirthealth.com) offers peer-reviewed multi-tradition health consultations that can help patients explore integrative approaches alongside conventional care.